NCT00003025View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 1997

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

vitespen

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER